Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio cut its position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 27.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,317 shares of the company's stock after selling 23,806 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.14% of Avanos Medical worth $992,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Avanos Medical by 10.9% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,269 shares of the company's stock worth $1,915,000 after purchasing an additional 11,799 shares in the last quarter. Two Sigma Investments LP increased its stake in Avanos Medical by 20.6% during the 4th quarter. Two Sigma Investments LP now owns 72,701 shares of the company's stock worth $1,157,000 after buying an additional 12,422 shares during the period. State of Wyoming lifted its holdings in Avanos Medical by 132.0% in the 4th quarter. State of Wyoming now owns 5,137 shares of the company's stock worth $82,000 after buying an additional 2,923 shares in the last quarter. ProShare Advisors LLC lifted its holdings in Avanos Medical by 44.4% in the 4th quarter. ProShare Advisors LLC now owns 13,693 shares of the company's stock worth $218,000 after buying an additional 4,210 shares in the last quarter. Finally, Occudo Quantitative Strategies LP purchased a new position in Avanos Medical in the 4th quarter valued at about $485,000. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Wall Street Zen raised Avanos Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

Avanos Medical Stock Down 1.1%

Shares of AVNS stock traded down $0.13 during mid-day trading on Thursday, reaching $12.34. 342,455 shares of the company were exchanged, compared to its average volume of 367,198. The company has a market capitalization of $570.56 million, a P/E ratio of 36.29 and a beta of 1.13. The business's 50 day simple moving average is $12.70 and its 200 day simple moving average is $15.11. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. Avanos Medical, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $25.36.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.07. The company had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The company's revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.22 EPS. Research analysts predict that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.